"We anticipate early safety results from this study could be available in the second half of 2021," a spokesperson for Pfizer tells PEOPLE in a statement
Watching
Latest
-
Wegman uses biometric surveillance on shoppers, raising privacy concerns
-
UK ordered agents to find UFO tech in bombshell 1990s secret files shocker | New York Post
-
Private equity barons target savers in hunt for ‘the perfect bailout’
-
Giant structure discovered deep beneath Bermuda is unlike anything else on Earth | Live Science